Inpellis, Inc.
Pharmaceutical company · Haddonfield, New Jersey, United States
Inpellis, Inc. is a pharmaceutical company headquartered in Haddonfield, New Jersey, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $4.3 million sold in a notice filed in 2015.
Inpellis at a glance
What does Inpellis do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $4.3 million sold (2015).
Frequently asked questions about Inpellis
Where is Inpellis headquartered?
Inpellis, Inc. is headquartered in Haddonfield, New Jersey, United States.
What does Inpellis do?
Inpellis, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Inpellis founded?
The earliest incorporation on record for Inpellis, Inc. is in 2012, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences